Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients

BACKGROUND: By the use of PSMA positron emission tomography (PET) detection of prostate cancer lesions with a high sensitivity and specificity combined with a favorable lesion to background contrast is feasible. Therefore, PSMA-PET is increasingly used for planning of radiotherapy treatment; however...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiat Oncol
Autors principals: Zschaeck, Sebastian, Wust, Peter, Beck, Marcus, Wlodarczyk, Waldemar, Kaul, David, Rogasch, Julian, Budach, Volker, Furth, Christian, Ghadjar, Pirus
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568206/
https://ncbi.nlm.nih.gov/pubmed/28830532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0877-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars